MCRB SERES THERAPEUTICS INC Management Changes 8-K Filing 2025 - Management Change On February 22, 2025, Lisa von Moltke, M.D. announced her resignation as Executive Vice President and Chief Medical Officer of Seres Therapeutics, effective March 14, 2025, to join another biopharmaceutical company.Get access to all SEC 8-K filings of the SERES THERAPEUTICS INC